Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: RE: Pure Speculation - TPL & PTSC merge - mvaar

RE: Pure Speculation - TPL & PTSC merge - mvaar

posted on Mar 10, 2006 02:12AM
TPL(P-Newco) already have ``full rights`` to litigate patent infringers, I am therefore at a loss to understand how merging TPL and PTSC will accrue even greater rights. Surely the incentive is to maximize returns and the early berths program enables this? How would you have suggested they go about it differently to achieve your $500 million+ settlements?

Without knowing how much cash has been retained, is it possible to state that, ``Pohl is giving away cash at a rate that is depreciating the stock`s PPS``?

If one acknowledges that Pohl is a shrewd operator, which I understand most do, is it not wiser to await the full details of his plan before suggesting that his method is erroneous for maximizing the PPS?

Be well

Share
New Message
Please login to post a reply